Crosstalk between the coagulation and complement systems in sepsis

Thrombosis Research

Volumn 133, Issue SUPPL. 1, 2014, Pages

  Lupu, Florea ^a   Keshari, Ravi S ^a   Lambris, John D ^b   Mark Coggeshall, K ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Coagulation; Complement; Disseminated intravascular coagulation; Inflammation; Multiple organ failure; Sepsis

Indexed keywords

ANTICOAGULANT PROTEIN; COMPLEMENT; COMPSTATIN; PEPTIDOGLYCAN; PROCOAGULANT; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BABOON; BACILLUS ANTHRACIS; BLOOD CLOTTING; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; THROMBOCYTOPENIA; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; DISSEMINATED INTRAVASCULAR COAGULATION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY;

ANIMALS; BLOOD COAGULATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; IMMUNITY, INNATE; PAPIO; SEPSIS;

EID: 84899006073     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.03.014     Document Type: Article

References (32)

1. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
2. F.B. Taylor Jr., G.T. Kinasewitz, and F. Lupu Pathophysiology, staging and therapy of severe sepsis in baboon models J Cell Mol Med 16 2012 672 682
3. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138 150
4. R.S. Keshari, R. Silasi-Mansat, H. Zhu, N.I. Popescu, G. Peer, and H. Chaaban et al. Acute Lung Injury and Fibrosis in a Baboon Model of E. coli Sepsis Am J Respir Cell Mol Biol 50 2014 439 450
5. J.K. Iyer, T. Khurana, M. Langer, C.M. West, J.D. Ballard, and J.P. Metcalf et al. Inflammatory cytokine response to Bacillus anthracis peptidoglycan requires phagocytosis and lysosomal trafficking Infect Immun 78 2010 2418 2428
6. R. Pawlinski, and N. Mackman Cellular sources of tissue factor in endotoxemia and sepsis Thromb Res 125 Suppl. 1 2010 S70 S73
7. C.T. Esmon The interactions between inflammation and coagulation Br J Haematol 131 2005 417 430
8. R. Silasi-Mansat, H. Zhu, N.I. Popescu, G. Peer, G. Sfyroera, and P. Magotti et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis Blood 116 2010 1002 1010
9. C. Lupu, A.D. Westmuckett, G. Peer, L. Ivanciu, H. Zhu, and F.B. Taylor Jr. et al. Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis Am J Pathol 167 2005 1161 1172
10. F.B. Taylor Jr., A. Chang, W. Ruf, J.H. Morrissey, L. Hinshaw, and R. Catlett et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody Circ Shock 33 1991 127 134
11. F.B. Taylor, A.C. Chang, G. Peer, A. Li, M. Ezban, and U. Hedner Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli Blood 91 1998 1609 1615
12. K.E. Welty-Wolf, M.S. Carraway, D.L. Miller, T.L. Ortel, M. Ezban, and A.J. Ghio et al. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons Am J Respir Crit Care Med 164 2001 1988 1996
13. K.F. Nickel, and T. Renne Crosstalk of the plasma contact system with bacteria Thromb Res 130 Suppl. 1 2012 S78 S83
14. E.I. Tucker, N.G. Verbout, P.Y. Leung, S. Hurst, O.J. McCarty, and D. Gailani et al. Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis Blood 119 2012 4762 4768
15. R.A. Pixley, R. De La Cadena, J.D. Page, N. Kaufman, E.G. Wyshock, and A. Chang et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons J Clin Invest 91 1993 61 68
16. H. Tang, L. Ivanciu, N. Popescu, G. Peer, E. Hack, and C. Lupu et al. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor Am J Pathol 171 2007 1066 1077
17. C. Lupu, O. Herlea, H. Tang, R.H. Lijnen, and F. Lupu Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia J Thromb Haemost 11 2013 142 148
18. C. Lupu, E.K. Kruithof, V.V. Kakkar, and F. Lupu Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons Thromb Haemost 82 1999 1652 1658
19. A.A. Creasey, A.C. Chang, L. Feigen, T.C. Wun, F.B. Taylor Jr., and L.B. Hinshaw Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock J Clin Invest 91 1993 2850 2860
20. F.B. Taylor Jr., E. Hack, and F. Lupu Observations on complement activity in the two-stage inflammatory/hemostatic response in the baboon and human models of E. coli sepsis and endotoxemia Adv Exp Med Biol 586 2006 203 216
21. T. Schuerholz, M. Leuwer, M. Cobas-Meyer, B. Vangerow, F. Kube, and M. Kirschfink et al. Terminal complement complex in septic shock with capillary leakage: marker of complement activation? Eur J Anaesthesiol 22 2005 541 547
22. C.E. Hack, J.H. Nuijens, R.J. Felt-Bersma, W.O. Schreuder, A.J. Eerenberg-Belmer, and J. Paardekooper et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis Am J Med 86 1989 20 26
23. J. Cohen The immunopathogenesis of sepsis Nature 420 2002 885 891
24. M.M. Markiewski, B. Nilsson, K.N. Ekdahl, T.E. Mollnes, and J.D. Lambris Complement and coagulation: strangers or partners in crime? Trends Immunol 28 2007 184 192
25. K. Ritis, M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, and P. Magotti et al. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways J Immunol 177 2006 4794 4802
26. F. Langer, B. Spath, C. Fischer, M. Stolz, F.A. Ayuk, and N. Kroger et al. Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase Blood 121 2013 2324 2335
27. P.J. Sims, E.M. Faioni, T. Wiedmer, and S.J. Shattil Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity J Biol Chem 263 1988 18205 18212
28. D. Sun, N.I. Popescu, B. Raisley, R.S. Keshari, G.L. Dale, and F. Lupu et al. Bacillus anthracis peptidoglycan activates human platelets through FcgammaRII and complement Blood 122 2013 571 579
29. M. Huber-Lang, J.V. Sarma, F.S. Zetoune, D. Rittirsch, T.A. Neff, and S.R. McGuire et al. Generation of C5a in the absence of C3: a new complement activation pathway Nat Med 12 2006 682 687
30. E.M. Conway Thrombomodulin and its role in inflammation Semin Immunopathol 34 2012 107 125
31. B. Ghebrehiwet, B.P. Randazzo, J.T. Dunn, M. Silverberg, and A.P. Kaplan Mechanisms of activation of the classical pathway of complement by Hageman factor fragment J Clin Invest 71 1983 1450 1456
32. A.E. Davis III, P. Mejia, and F. Lu Biological activities of C1 inhibitor Mol Immunol 45 2008 4057 4063